MedTrace Logo

Vitamin C to Reduce Vasopressor Dose in Septic Shock

NCT03835286 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-01-18

No results posted yet for this study

Summary

Randomized, controlled, double blind clinical trial. Adult patients admitted to the ICU of the Hospital Español de México with a diagnosis of septic shock will be included.

Patients will be randomized to one of the study groups:

Intervention Group: Vitamin C 6 grams in 250 ml of 0.9% saline solution every 24 hours, in continuous infusion for 72 hours.

Placebo Group: 0.9% saline solution 250 ml every 24 hours, in continuous infusion for 72 hours.

Conditions

Interventions

DRUG

Vitamin C

6 grams of Vitamin C in 250 ml of 0.9% saline in continuous infusion for 24 hours, 3 doses.

DRUG

Placebos

Placebos: 250 ml of 0.9% saline in continuous infusion for 24 hours, 3 doses.

Sponsors & Collaborators

  • Hospital Español de Mexico

    lead OTHER

Principal Investigators

  • Ricardo Martinez-Zubieta, MD · Hospital Español de Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835286 on ClinicalTrials.gov